Candidal dermatitis, also known as a yeast infection rash or candidal intertrigo, is characterized by inflamed skin often found in skin folds. This page provides information on diagnosis, treatment, and clinical documentation of candidal dermatitis, including diaper rash with Candida. Learn about relevant medical coding terms and healthcare best practices for managing this common skin condition.
Fungal skin infection caused by Candida species, often in warm, moist areas.
Red, itchy rash with satellite pustules or papules, may have white plaques.
Skin folds, diaper area, under breasts, oral mucosa, vagina.
Complete code families applicable to B37.2
| Description | When to use |
|---|---|
| Yeast infection of the skin. | Skin rash in warm, moist areas, often with satellite lesions. Infants, obese, diabetics. |
| Fungal skin infection, not Candida. | Scaly, itchy rash, often ring-shaped. Consider KOH test. Exclude tinea capitis, tinea unguium. |
| Skin inflammation, not infectious. | Red, itchy rash, various patterns. Consider contact dermatitis, eczema, psoriasis. No satellite lesions. |
Coding candidal dermatitis without specifying the affected body area can lead to claim rejections and inaccurate data reporting. Use site-specific codes for proper reimbursement.
Diaper rash with candida requires a specific code distinct from general diaper rash. Incorrect coding impacts quality metrics and reimbursement.
Insufficient documentation of candidal infection confirmation (e.g., KOH test) can cause coding audits to flag claims for lacking medical necessity.
Confirm rash location: skin folds, groin, armpits, under breasts
Check for satellite lesions: small pustules surrounding main rash
KOH microscopy: pseudohyphae and budding yeast cells present
Consider risk factors: obesity, diabetes, antibiotic use, immunocompromised
Patient presents with clinical manifestations consistent with candidal dermatitis (ICD-10 code B37.2). The affected area, located in [Location - e.g., the inguinal folds, axillae, perianal region], exhibits erythema, satellite lesions, and maceration. Symptoms reported include pruritus, burning sensation, and occasional malodor. Differential diagnoses considered include intertrigo, contact dermatitis, and psoriasis. Given the characteristic presentation of satellite lesions and the patient's history of [Predisposing factors - e.g., recent antibiotic use, diabetes, obesity, immunocompromised state], a clinical diagnosis of candidal dermatitis, also known as a yeast infection rash or candidal intertrigo, is made. In infants, this presentation may be consistent with diaper rash with Candida. Microscopic examination with potassium hydroxide (KOH) preparation was performed, revealing pseudohyphae and budding yeast cells, confirming the diagnosis. Treatment plan includes topical antifungal therapy with [Medication name and dosage - e.g., clotrimazole cream 1% applied twice daily for two weeks]. Patient education provided on proper hygiene practices, including keeping the affected area clean and dry, and avoiding tight-fitting clothing. Follow-up appointment scheduled in two weeks to assess treatment response and adjust management as needed.
Differentiating candidal intertrigo from other intertriginous dermatoses like intertrigo caused by dermatophytes, psoriasis, or contact dermatitis in obese adult patients requires careful clinical evaluation and, sometimes, diagnostic tests. Candidal intertrigo typically presents as beefy-red plaques with satellite pustules or papules, often with peripheral scaling, within skin folds. A KOH preparation can confirm the presence of Candida species. While intertrigo caused by dermatophytes may appear similar, it often involves more central clearing. Psoriasis in intertriginous areas may present with well-defined erythematous plaques, but lacks satellite lesions. Contact dermatitis may mimic candidal intertrigo, but history of exposure to irritants or allergens is key. Consider implementing a stepwise approach involving visual inspection, KOH microscopy, and, if necessary, a skin biopsy for definitive diagnosis. Explore how specific patient factors, like diabetes or immunosuppression, may influence presentation and management.
Topical antifungals are the cornerstone of treating candidal diaper dermatitis in infants. Nystatin is a commonly used and safe option, though its efficacy may be slightly lower than azoles. Imidazole antifungals, like clotrimazole or miconazole, are generally considered first-line due to their broad spectrum and efficacy. However, some imidazoles can be more irritating than nystatin. For severe or resistant cases, consider topical ketoconazole 2% cream, though it is essential to monitor for potential systemic absorption, especially in infants with compromised skin barriers. Barrier creams containing zinc oxide or dimethicone can be used adjunctively to protect the skin and prevent further irritation. Learn more about the importance of good hygiene practices and frequent diaper changes in conjunction with topical treatment. Explore how factors such as duration of treatment, choice of topical agent, and concomitant skin conditions can influence treatment success.
Cutaneous candidiasis in immunocompromised patients can present atypically and be more severe than in immunocompetent individuals. While typical presentations like intertrigo or diaper rash can occur, these patients are also at risk for more disseminated or invasive forms. Clinical features can range from erythematous macules and papules to pustules, nodules, or even ulcers. Paronychia and onychomycosis are also common. A thorough history, including immune status and medications, is crucial. KOH preparation and fungal culture are essential for confirming the diagnosis and identifying the specific Candida species. In disseminated cases, blood cultures and tissue biopsies may be necessary. Consider implementing prompt antifungal treatment, considering factors like the patient's immune status, disease severity, and potential drug interactions. Explore how different antifungal agents, including topical, oral, and intravenous options, are utilized in managing cutaneous candidiasis in immunocompromised patients.
Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.
Coding standard: ICD-10-CM, current FY guidelines.